Zentek Ltd. (ZTEK)
NASDAQ: ZTEK · Real-Time Price · USD
0.5923
-0.0024 (-0.40%)
At close: Feb 20, 2026, 4:00 PM EST
0.6041
+0.0118 (1.99%)
After-hours: Feb 20, 2026, 4:48 PM EST
Zentek Revenue
Zentek had revenue of 65.28K CAD in the quarter ending December 31, 2025, with 73.07% growth. This brings the company's revenue in the last twelve months to 942.88K, up 1,358.30% year-over-year. In the fiscal year ending March 31, 2025, Zentek had annual revenue of 872.50K with 2,826.26% growth.
Revenue (ttm)
942.88K CAD
Revenue Growth
+1,358.30%
P/S Ratio
91.37
Revenue / Employee
37,715 CAD
Employees
25
Market Cap
62.83M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 872.50K | 842.68K | 2,826.26% |
| Mar 31, 2024 | 29.82K | -43.04K | -59.07% |
| Mar 31, 2023 | 72.86K | -613.99K | -89.39% |
| Mar 31, 2022 | 686.85K | 684.49K | 29,065.56% |
| Mar 31, 2021 | 2.36K | -37.22K | -94.05% |
| Mar 31, 2020 | 39.57K | - | - |
| Mar 31, 2019 | - | - | - |
| Mar 31, 2018 | - | - | - |
| Mar 31, 2017 | - | - | - |
| Mar 31, 2016 | - | - | - |
| Mar 31, 2015 | - | - | - |
| Mar 31, 2014 | - | - | - |
| Mar 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanara MedTech | 101.88M |
| Harvard Bioscience | 87.37M |
| Pro-Dex | 72.10M |
| Precision Optics Corporation | 24.42M |
| Jin Medical International | 20.69M |
| Nephros | 17.93M |
| Ekso Bionics Holdings | 14.75M |
| Femasys | 2.06M |
ZTEK News
- 5 days ago - Zentek Provides Strategic and Regulatory Update - Accesswire
- 24 days ago - Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan - Newsfile Corp
- 6 weeks ago - Zentek's Albany Graphite Has Demonstrated Nuclear Grade Performance in Independent Testing, Opening Pathways Into a Range of High-Return Commercial Markets - Accesswire
- 2 months ago - Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing - Accesswire
- 3 months ago - Zentek Announces Appointment of Mohammed Jiwan as Chief Executive Officer - Accesswire
- 3 months ago - Zentek Receives CRA Notice of Reassessment for 2019 - Accesswire
- 3 months ago - Zentek Announces the Development of a New Graphite Gel-Based Fire-Retardant Product and an Exclusive Licence with Altek Advanced Materials Inc. for the US Market - Accesswire
- 4 months ago - Zentek Announces Closing of Non-Brokered Private Placement of Units for Gross Proceeds of $2,479,227 - Newsfile Corp